Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Basis Corporation Registered Shs Aktie 111766377 / JP3835270004

29.10.2025 08:00:57

Bitcoin Cost Basis Map Reveals Key War Zone Between Bulls & Bears

On-chain analytics firm Glassnode has revealed a Bitcoin price range that defines the current battleground between recent buyers and profit-takers.Bitcoin Cost Basis Distribution Shows Where Resistance & Support Are StrongestIn a new post on X, Glassnode has talked about where support and resistance levels lie for Bitcoin based on the Cost Basis Distribution (CBD). This indicator basically tells us about the total amount of supply that last changed hands at the various price levels that the cryptocurrency has visited in its history.Below is the chart shared by the analytics firm that shows the trend in this metric over the last few months.As is visible in the graph, the CBD highlights two levels for holding a dense amount of the cryptocurrency’s supply (shaded in red). The lower of these levels is situated near $111,000. A large chunk of buying at this mark occurred during the recent bearish phase in the asset.The other level is located around $117,000, made up of investors who bought during the price rally to the all-time high (ATH). Naturally, these buyers would be underwater right now, while those who purchased at $111,000 would be in profit.Generally, holders are sensitive to retests of their cost basis and can show some kind of reaction during one. Since these two levels host the cost basis of a significant amount of investors, it’s possible that when BTC will revisit them, some panic selling or buying will crop up.Which behavior would be dominant usually comes down to the market mood and the direction of the retest. When the retest occurs from above, investors may choose to buy more, believing the same cost basis level would result in profits again in the future. Similarly, holders who were in loss prior to the retest can react by selling, fearing that the asset will drop again in the future.Considering these effects, the $111,000 may be considered a key support cushion for Bitcoin, while $117,000 a resistance barrier. “This range defines the current battleground between recent buyers and profit-takers,” noted Glassnode.It now remains to be seen which level BTC will visit next and how its retest will go. “A break in either direction could set the tone for the next major move,” explained the analytics firm.In some other news, the Stablecoin Supply Ratio (SSR) Oscillator has been sitting at cycle lows recently, as Glassnode has pointed out in another X post. This oscillator is based on the SSR, which compares the Bitcoin circulating supply against the supply of the stablecoins.The SSR Oscillator is sitting at a low level at the moment, which indicates that the BTC supply is low compared to stablecoin liquidity. “Historically, such periods precede stronger bid-side support when market confidence returns,” said the analytics firm.BTC PriceBitcoin saw a retrace toward $113,500 earlier, but the coin has been quick to bounce back as its price has returned to $115,400.Weiter zum vollständigen Artikel bei NewsBTC

Analysen zu Basis Corporation Registered Shs

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Im BX Morning Call spricht die Schweizer Unternehmer-Ikone Etienne Jornod (OM Pharma) mit François Bloch und Olivia Hähnel (BX Swiss) über Führung, Wachstum, Kooperationen, seine Zeit bei der NZZ und darüber, warum Zuhören der wichtigste Leadership-Skill ist.

Die perfekte Folge für alle, die sich für Pharmastrategien, Galenica/Vifor und Unternehmertum interessieren.

🎯 Themen im Interview mit Etienne Jornod (OM Pharma)

– Antrieb und Führungsphilosophie eines Unternehmers
– Erfolgsweg von Galenica – Lehren aus Jahrzehnten Führung
– Frauenquote, Teamkultur und Leadership bei OM Pharma
– Internationale Expansion: China, USA und neue Märkte
– Forschung, Druck und Verantwortung in der Pharmaindustrie
– Inspiration, Balance und persönliche Haltung zum Erfolg
– Zukunftsvisionen: Schweiz, Unternehmertum und Investments

👉🏽 https://bxplus.ch/bx-musterportfolio/

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’823.22 19.56 S2S3VU
Short 13’094.83 13.71 UEBSLU
Short 13’580.05 8.95 UJOBSU
SMI-Kurs: 12’314.10 29.10.2025 17:31:05
Long 11’736.05 18.56 SHFB5U
Long 11’507.12 13.87 BIYSFU
Long 11’008.02 8.95 BMQS4U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com